Real-time enrollment status for this pancreatic ductal adenocarcinoma clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 10:52 AM UTC
| NCT Number | NCT07024615 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Ductal Adenocarcinoma |
| Phase | PHASE1 |
| Target Enrollment | 25 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Astellas Pharma Global Development, Inc. |
| Last Updated on CT.gov | July 15, 2026 (Jul 15, 2026) |
As of August 28, 2026: Clinical trial NCT07024615 is currently recruiting participants. This phase1 study for pancreatic ductal adenocarcinoma is actively seeking new participants at 3 locations across the United States. The study is sponsored by Astellas Pharma Global Development, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07024615 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07024615 was last updated Jul 15, 2026 (July 15, 2026). HelloStudys verifies this status automatically.